Apogee Therapeutics, Inc. company logo
Apogee Therapeutics, Inc. logo

Apogee Therapeutics, Inc. (APGE) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$141.79M$23.47M+19.84%

Summary

Current Value
As of today, APGE annual cash & cash equivalents is $141.79M, up +19.84% on
Historical Performance
APGE annual cash & cash equivalents is down -6.65% over the past 3 years, and down -6.65% over the past 5 years
All-Time High Comparison
APGE annual cash & cash equivalents is currently -6.65% below its historical high of $151.89M set on
3-Year Low Comparison
APGE annual cash & cash equivalents is +19.84% above its 3-year low of $118.32M reached on
Sector Comparison
APGE annual cash & cash equivalents is higher than 71.61% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

APGE Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$141.79M+19.8%-6.7%-6.7%-6.7%
Quarterly Cash & Cash Equivalents$527.29M+0.2%
Price$76.42+55.3%
Annual Current Assets$529.71M+33.0%+248.4%+248.4%+248.4%
Annual Total Liabilities$37.16M+72.9%+272.3%+272.3%+272.3%
Annual Working Capital$501.15M+32.6%+252.7%+252.7%+252.7%
Annual Net Income-$182.15M-116.9%-357.8%-357.8%-357.8%

Cash and Cash Equivalents Highs

APGE Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$151.89MN/A-6.7%
5Y$151.89M-6.7%
All$151.89M-6.7%

Cash and Cash Equivalents Lows

APGE Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$118.32M+19.8%
5Y$118.32M+19.8%
All$118.32M+19.8%

Cash and Cash Equivalents History

YearValueChange
$141.79M+19.8%
$118.32M-22.1%
YearValueChange
$151.89M-

FAQ

  • What is the current annual cash & cash equivalents of APGE?

    As of today, APGE annual cash & cash equivalents is $141.79M

  • What is 1-year change in APGE annual cash & cash equivalents?

    APGE annual cash & cash equivalents is up +19.84% year-over-year

  • What is 3-year change in APGE annual cash & cash equivalents?

    APGE annual cash & cash equivalents is down -6.65% over the past 3 years

  • How far is APGE annual cash & cash equivalents from its all-time high?

    APGE annual cash & cash equivalents is currently -6.65% below its historical high of $151.89M set on December 31, 2022

  • How does APGE annual cash & cash equivalents rank versus sector peers?

    APGE annual cash & cash equivalents is higher than 71.61% of companies in Healthcare sector

  • When is APGE next annual earnings release?

    The next annual earnings release for APGE is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. APGE Official Website www.apogeetherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1974640/000119312525273260/0001193125-25-273260-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1974640/000095017025030385/0000950170-25-030385-index.htm
  4. APGE Profile on Yahoo Finance finance.yahoo.com/quote/APGE
  5. APGE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/apge